{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:10:26Z","timestamp":1788754226872,"version":"build-2803163510"},"reference-count":44,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T00:00:00Z","timestamp":1614038400000},"content-version":"unspecified","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2021,1,31]]},"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Early use of insertable cardiac monitor (ICM) is recommended for patients with unexplained syncope following initial clinical workup, due to its superior ability to establish symptom-rhythm correlation compared with conventional testing (CONV). However, ICMs incur higher upfront costs, and the impact of additional diagnoses and resulting treatment on downstream costs and outcomes is unclear. We aimed to evaluate the cost-effectiveness of ICM compared with CONV for the diagnosis of arrhythmia in patients with unexplained syncope, from a US payer perspective.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A Markov model was developed to estimate lifetime costs and benefits of arrhythmia diagnosis with ICM versus CONV, considering all related diagnostic and arrhythmia-related treatment costs and consequences. Cohort characteristics and costs were informed by original claims database analyses. Risks of mortality, syncopal recurrence, injury due to syncope and quality of life consequences from syncopal events were identified from the literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>ICM was less costly and more effective than CONV. Most of the observed US$4532 cost savings were attributed to reduced downstream diagnostic testing. For every 1000 patients, ICM was projected to yield an additional 253 arrhythmia diagnoses and lead to treatment in an additional 168 patients. The ICM strategy resulted in overall improved outcomes (0.30 quality-adjusted life years gained), due to a reduction in syncope recurrence and injury resulting from arrhythmia treatment. The results were robust to changes in the base case parameters but sensitive to the model time horizon, underlying probability of syncope recurrence and prevalence of arrhythmias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our model projected that early ICM for the diagnosis of unexplained syncope reduced long-term costs, and led to an improvement in overall clinical outcomes by shortening time to arrhythmia treatment. The cost of ICM was outweighed by savings arising from fewer downstream diagnostic episodes, and the increased cost of treatment was counterbalanced by fewer syncope-related event costs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/openhrt-2020-001263","type":"journal-article","created":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T10:59:00Z","timestamp":1614077940000},"page":"e001263","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Economic value of insertable cardiac monitors in unexplained syncope in the United States"],"prefix":"10.1136","volume":"8","author":[{"given":"Brad S","family":"Sutton","sequence":"first","affiliation":[{"name":"University of Louisville, Louisville, Kentucky, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L","family":"Bermingham","sequence":"additional","affiliation":[{"name":"Symmetron Ltd, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Diamantopoulos","sequence":"additional","affiliation":[{"name":"Symmetron Ltd, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8864-2734","authenticated-orcid":false,"given":"Sarah C","family":"Rosemas","sequence":"additional","affiliation":[{"name":"Medtronic Inc, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stelios I","family":"Tsintzos","sequence":"additional","affiliation":[{"name":"Health Economics and Reimbursement, Medtronic Europe SA, Tolochenaz, Vaud, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xia","sequence":"additional","affiliation":[{"name":"Medtronic Inc, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Cardiovascular Medicine, Baim Institute for Clinical Research, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,2,23]]},"reference":[{"key":"2025081710562134000_8.1.e001263.1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00260"},{"key":"2025081710562134000_8.1.e001263.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012407"},{"key":"2025081710562134000_8.1.e001263.3","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/eurheartj\/ehy037","article-title":"2018 ESC guidelines for the diagnosis and management of syncope","volume":"39","author":"Brignole","year":"2018","journal-title":"Eur Heart J"},{"key":"2025081710562134000_8.1.e001263.4","unstructured":"National Institute of Health and Care Excellence . Transient loss of consciousness ('blackouts') in over 16S. clinical guideline 109. London, UK 2010 https:\/\/www.nice.org.uk\/guidance\/cg109\/evidence (Accessed March 9, 2018)."},{"key":"2025081710562134000_8.1.e001263.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2017.03.004"},{"key":"2025081710562134000_8.1.e001263.6","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2012-302851"},{"key":"2025081710562134000_8.1.e001263.7","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eur343"},{"key":"2025081710562134000_8.1.e001263.8","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2261-14-1"},{"key":"2025081710562134000_8.1.e001263.9","doi-asserted-by":"crossref","first-page":"A116","DOI":"10.1016\/j.jval.2014.03.677","article-title":"The cost-effectiveness of detecting arrhythmia with implantable loop recorders in the United state of America","volume":"17","author":"Rogers","year":"2014","journal-title":"Value in Health"},{"key":"2025081710562134000_8.1.e001263.10","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X09345022"},{"key":"2025081710562134000_8.1.e001263.11","doi-asserted-by":"crossref","unstructured":"Neumann PJ , Ganiats TG , Russell LB , et al . Cost-effectiveness in health and medicine. Online: Oxford Scholarship Online, 2016.","DOI":"10.1093\/acprof:oso\/9780190492939.001.0001"},{"key":"2025081710562134000_8.1.e001263.12","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/acem.12720","article-title":"National cost savings from observation unit management of syncope","volume":"22","author":"Baugh","year":"2015","journal-title":"Acad Emerg Med"},{"key":"2025081710562134000_8.1.e001263.13","doi-asserted-by":"crossref","first-page":"A44","DOI":"10.1016\/j.jval.2015.03.264","article-title":"Cost-Effectiveness analysis of external looping recording compared to Holter monitoring for syncope in Colombia","volume":"18","author":"Orozco","year":"2015","journal-title":"Value in Health"},{"key":"2025081710562134000_8.1.e001263.14","unstructured":"Symmetron Inc . Cost-effectiveness of reveal in the detection of arrhythmia: a USA perspective. data on file. Medtronic Inc., 2013. accessed."},{"key":"2025081710562134000_8.1.e001263.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehj.2004.03.010"},{"key":"2025081710562134000_8.1.e001263.16","unstructured":"Centers for Disease Control and Prevention . United States life tables, 2014. Available: https:\/\/www.cdc.gov\/nchs\/products\/life_tables.htm [Accessed April 10, 2018]."},{"key":"2025081710562134000_8.1.e001263.17","doi-asserted-by":"publisher","DOI":"10.1177\/2047487316632628"},{"key":"2025081710562134000_8.1.e001263.18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijcard.2016.12.128","article-title":"The diagnostic yield of implantable loop recorders in unexplained syncope: a systematic review and meta-analysis","volume":"231","author":"Solbiati","year":"2017","journal-title":"Int J Cardiol"},{"key":"2025081710562134000_8.1.e001263.19","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm563"},{"key":"2025081710562134000_8.1.e001263.20","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi842"},{"key":"2025081710562134000_8.1.e001263.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199711273372202"},{"key":"2025081710562134000_8.1.e001263.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2009.04.040"},{"key":"2025081710562134000_8.1.e001263.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2006.00533.x"},{"key":"2025081710562134000_8.1.e001263.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2008.00352.x"},{"key":"2025081710562134000_8.1.e001263.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2004.10.019"},{"key":"2025081710562134000_8.1.e001263.26","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eup414"},{"key":"2025081710562134000_8.1.e001263.27","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eup106"},{"key":"2025081710562134000_8.1.e001263.28","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.93.5.973"},{"key":"2025081710562134000_8.1.e001263.29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4236\/health.2013.512A007","article-title":"Falls and health-related quality of life (SF-36) in elderly people\u2014ISACAMP 2008","volume":"05","author":"Rodrigues","year":"2013","journal-title":"Health"},{"key":"2025081710562134000_8.1.e001263.30","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/europace\/euq418","article-title":"Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope: results from the PICTURE registry","volume":"13","author":"Edvardsson","year":"2011","journal-title":"Europace"},{"key":"2025081710562134000_8.1.e001263.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.06.012"},{"key":"2025081710562134000_8.1.e001263.32","unstructured":"Institute for Clinical and Economic Review (ICER) . A guide to ICER\u2019s methods for health technology assessment, 2018. Available: http:\/\/icer-review.org\/wp-content\/uploads\/2018\/08\/ICER-HTA-Guide_082018.pdf [Accessed July 8, 2018]."},{"key":"2025081710562134000_8.1.e001263.33","unstructured":"National Institute for Health and Care Excellence (NICE) . Guide to the methods of technology appraisal 2013, 2018. Available: www.nice.org.uk\/process\/pmg9 [Accessed July 8, 2019]."},{"key":"2025081710562134000_8.1.e001263.34","unstructured":"ClinicalTrials.gov . ClinicalTrials.gov Identifier: NCT02817906. ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer\u2019s Disease, 2018. Available: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02817906 [Accessed December 14, 2018]."},{"key":"2025081710562134000_8.1.e001263.35","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02621-9"},{"key":"2025081710562134000_8.1.e001263.36","doi-asserted-by":"crossref","unstructured":"Frazier-Mills CG , Johnson LC , Xia Y , et al . Lower rates of syncope recurrence and less downstream diagnostic testing after Insertable cardiac monitor placement for syncope. American Cardiology Conference, New Orleans, USA, 2019.","DOI":"10.1016\/S0735-1097(19)31034-4"},{"key":"2025081710562134000_8.1.e001263.37","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.104.1.46"},{"key":"2025081710562134000_8.1.e001263.38","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.3.406"},{"key":"2025081710562134000_8.1.e001263.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2014.05.009"},{"key":"2025081710562134000_8.1.e001263.40","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euv228"},{"key":"2025081710562134000_8.1.e001263.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.05.003"},{"key":"2025081710562134000_8.1.e001263.42","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39227.551713.AE"},{"key":"2025081710562134000_8.1.e001263.43","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi602"},{"key":"2025081710562134000_8.1.e001263.44","unstructured":"Musat D et al . Understanding automatic connectivity limitations in patients undergoing long-term ECG monitoring with an implantable cardiac monitor. Heart Rhythm Sessions 2017."}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2020-001263","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T17:56:29Z","timestamp":1755453389000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2020-001263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,2,23]]},"published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10.1136\/openhrt-2020-001263"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2020-001263","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]}}}